Biopsy Devices Market Size By Product (Biopsy Guidance Systems [Manual, Robotic], Needle Based Biopsy Guns [Vacuum-Assisted, Fine Needle, Core Needle] Biopsy Devices [Disposable, Reusable], Biopsy Forceps [General Biopsy, Hot Biopsy]), By End-use (Hospita

Biopsy Devices Market Size By Product (Biopsy Guidance Systems [Manual, Robotic], Needle Based Biopsy Guns [Vacuum-Assisted, Fine Needle, Core Needle] Biopsy Devices [Disposable, Reusable], Biopsy Forceps [General Biopsy, Hot Biopsy]), By End-use (Hospitals, Ambulatory Surgical Centers), Regional Outlook, Industry Analysis Report, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032


Global Biopsy Devices Market is slated to expand exponentially through 2032, owing to the technological advancements in biopsy devices development. In addition, the widespread usage of biopsy tract ablation devices equipped with lasers, radiofrequency, and other technological developments in various applications is further slated to influence the market outlook over the estimated timeframe.

In addition, the availability of cutting-edge technologies for tissue scanning and detecting small cancerous tumors is estimated to enhance the industry expansion. Citing an instance, in 2022, a team of researchers from the Technical University of Munich incorporated the dark-field X-ray approach into a CT scanner, which is highly appropriate for clinical use. In addition to traditional X-ray imaging, dark-field imaging also offers additional information. The new prototype development would now make 3D dark-field X-ray images creation quite easy.

Besides, the global industry will likely foresee hindrances due to the lack of highly skilled professionals in the field. The biopsy procedures require strong technical expertise considering the complex equipment handling and interpretation of results.

Nevertheless, the launch of new technologies and several initiatives taken by the government in high-income countries will further positively influence the industry outlook.

The competitive landscape of the global biopsy device industry is highly intact. The key market players are constantly engaging in strategic initiatives, such as investing in R&D and undertaking mergers, acquisitions, and partnerships, to bolster their presence in the industry.

Overall, the global biopsy devices market is segmented in terms of product, end-user, and region.

Considering the product, the biopsy guidance system held the approximately 40% market share in 2022 and is slated to grow exponentially through 2032. Product benefits such as high-definition images, better accuracy, and outcomes are expected to spur the adoption, thereby resulting in segmental expansion.

Based on end-users, the others segment was valued over USD 270 million in 2022 and is slated to grow exponentially over 2023-2032. In addition, the other segment includes diagnostic centers, clinics, and research institutes, where the demand for biopsy devices is projected to grow notably through the coming years.

Regionally, the Asia Pacific global biopsy device market is expected to reach over USD 1.2 billion by 2032, owing to the presence of key players focusing on empowering their footprint in the region. In addition, large patient pool suffering from chronic illnesses with several technological advancements will drive the regional growth through 2032.